Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
XxU8bt9qN8QNCTnd
